Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tongzhen Xu

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Journal of Investigative Medicine High Impact Case Reports|December 17, 2024
Rare Pulmonary MALT Lymphomas and Its Differential Diagnosis On Chest CTTongzhen Xu, Shulan Zhang, Fang Liu
Anti-Cancer Agents in Medicinal Chemistry|May 16, 2012
Dual roles of sulforaphane in cancer treatmentTongzhen Xu, Dongmei Ren, Xuefei Sun, et al.
Frontiers in Immunology|April 27, 2023
Corrigendum: Toxicity profile of combined immune checkpoint inhibitors and thoracic radiotherapy in esophageal cancer: A meta-analysis and systematic reviewTongzhen Xu, Yunsong Liu, Xiaotong Lu, et al.
Frontiers in Immunology|November 28, 2022
Toxicity profile of combined immune checkpoint inhibitors and thoracic radiotherapy in esophageal cancer: A meta-analysis and systematic reviewTongzhen Xu, Yunsong Liu, Xiaotong Lu, et al.
Frontiers in Medicine|July 25, 2022
Resection of Thymic Neuroendocrine Carcinoma Guided by Three-Dimensional Reconstruction: A Case ReportFang Liu, Hengxiao Lu, Liqian Chen, et al.
Cytotechnology|June 21, 2021
MiR-522-3p inhibits proliferation and activation by regulating the expression of SLC31A1 in T cellsHengxiao Lu, Hao Wang, Peidao Sun, et al.
Cytotechnology|October 22, 2024
Retraction Note: MiR-522-3p inhibits proliferation and activation by regulating the expression of SLC31A1 in T cellsHengxiao Lu, Hao Wang, Peidao Sun, et al.
Journal of Thoracic Disease|January 22, 2016
A comparison of short-term outcomes between Ivor-Lewis and McKeown minimally invasive esophagectomyChunbo Zhai, Yongjing Liu, Wei Li, et al.
Pathogens (Basel, Switzerland)|December 31, 2025
Identification of Oral Microbiome Biomarkers Associated with Lung Cancer Diagnosis and Radiotherapy Response PredictionXiaoqian Shi, Nan Bi, Wenyang Liu, et al.
International Journal of Radiation Oncology, Biology, Physics|January 15, 2025
Quality of Life and Functional Outcomes in Patients With Locally Advanced Rectal Cancer Receiving Total Neoadjuvant Therapy Versus Concurrent Chemoradiation Therapy: An Analysis of the STELLAR TrialHuiying Ma, Haoyue Li, Tongzhen Xu, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Journal of Investigative Medicine High Impact Case Reports|December 17, 2024
Rare Pulmonary MALT Lymphomas and Its Differential Diagnosis On Chest CTTongzhen Xu, Shulan Zhang, Fang Liu
Anti-Cancer Agents in Medicinal Chemistry|May 16, 2012
Dual roles of sulforaphane in cancer treatmentTongzhen Xu, Dongmei Ren, Xuefei Sun, et al.
Frontiers in Immunology|April 27, 2023
Corrigendum: Toxicity profile of combined immune checkpoint inhibitors and thoracic radiotherapy in esophageal cancer: A meta-analysis and systematic reviewTongzhen Xu, Yunsong Liu, Xiaotong Lu, et al.
Frontiers in Immunology|November 28, 2022
Toxicity profile of combined immune checkpoint inhibitors and thoracic radiotherapy in esophageal cancer: A meta-analysis and systematic reviewTongzhen Xu, Yunsong Liu, Xiaotong Lu, et al.
Frontiers in Medicine|July 25, 2022
Resection of Thymic Neuroendocrine Carcinoma Guided by Three-Dimensional Reconstruction: A Case ReportFang Liu, Hengxiao Lu, Liqian Chen, et al.
Cytotechnology|June 21, 2021
MiR-522-3p inhibits proliferation and activation by regulating the expression of SLC31A1 in T cellsHengxiao Lu, Hao Wang, Peidao Sun, et al.
Cytotechnology|October 22, 2024
Retraction Note: MiR-522-3p inhibits proliferation and activation by regulating the expression of SLC31A1 in T cellsHengxiao Lu, Hao Wang, Peidao Sun, et al.
Journal of Thoracic Disease|January 22, 2016
A comparison of short-term outcomes between Ivor-Lewis and McKeown minimally invasive esophagectomyChunbo Zhai, Yongjing Liu, Wei Li, et al.
Pathogens (Basel, Switzerland)|December 31, 2025
Identification of Oral Microbiome Biomarkers Associated with Lung Cancer Diagnosis and Radiotherapy Response PredictionXiaoqian Shi, Nan Bi, Wenyang Liu, et al.
International Journal of Radiation Oncology, Biology, Physics|January 15, 2025
Quality of Life and Functional Outcomes in Patients With Locally Advanced Rectal Cancer Receiving Total Neoadjuvant Therapy Versus Concurrent Chemoradiation Therapy: An Analysis of the STELLAR TrialHuiying Ma, Haoyue Li, Tongzhen Xu, et al.
Pageof 2